Effect of Remazolam Besylate Combined With Remifentanil Analgesic Sedation on the Prognosis of Patients With Sepsis

NCT06731088 · clinicaltrials.gov ↗

PHASE4

Phase

ENROLLING_BY_INVITATION

Status

100

Enrollment

NETWORK

Sponsor class

Conditions

Sepsis

Interventions

DRUG: Midazolam
DRUG: Remazolam besylate

Sponsor

First Affiliated Hospital of Ningbo University